Literature overview nutritional components and their effect on the immune system via TLRs
Receptor | Nutritional Activator | Concentration and Mode of Administration | Type of Study | Model | Stimulant/Disease Model | Effect | Reference |
---|---|---|---|---|---|---|---|
TLR2 | Normal or Western-like rodent diet | Ad libitum | In vivo | WT and TLR2/4 double-KO C57BL6 | Crossfostering and TLR4 specific inhibitor TAK-242 | Maternal Western diet caused neonatal toxicity and inflammation, possibly related to long-chain fatty acids and SFAs in mother milk. TLR2/4 deletion rescues the neonatal toxicity | (Du et al., 2012) |
Free fatty acids | 500 µM | In vitro/ex vivo | RAW264.7 cells and BMDC from WT and TLR2/4 double-KO C57BL/6 mice | RAW264.7 cells were treated with siRNA-TLR2/4 | Increase in proinflammatory cytokines | (Nguyen et al., 2007) | |
β2→1-fructan | 1 or 100 µg/ml | In vitro | Human PBMC, THP-1 cells, and TLR2 reporter cell lines | — | Elevated IL-10/IL-12 protein levels | (Vogt et al., 2013) | |
β2→1-fructan | 100 mg/l | In vitro | T84 cells | Phorbol 12-myrestare 13-acetate and TLR2 blocking antibody | Improvement of intestinal epithelial barrier function | (Vogt et al., 2014) | |
TLR4 | FOS, inulin, GOS, and goat milk oligosaccharides | 0.005 –5 g/l | In vitro/ex vivo | Human peripheral blood monocytes, monocytes and lymphocytes from Wistar rats, and splenocytes from WT and TLR4−/− C57BL/6J mice | LPS, concanavalin A, and MAPK inhibitors | NDOs generally evoked cytokine release by splenocytes and monocytes, possibly via activation of TLR4 and engagement of NF-ĸB and MAPK pathways NF-ĸB | (Capitán-Cañadas et al., 2014) |
Normal or Western-like rodent diet | Ad libitum | In vivo | WT and TLR2/4 double-KO C57BL6 | Crossfostering and TLR4-specific inhibitor TAK-242 | Maternal Western diet caused neonatal toxicity and inflammation, possibly related to long-chain fatty acids and SFAs in mother milk. TLR2/4 deletion rescues the neonatal toxicity | (Du et al., 2012) | |
Sodium palmitate and laurate | 100–500 µM | In vitro | RAW 264.7 cells, immortalized MyD88−/− macrophages, and HEK293T cells | Bovine serum albumin and polymyxin B and TLR4-specific inhibitor TAK-242 | Induction of COX-2 and TNF-α | (Huang et al., 2012) | |
Sialyl(α2,3)lactose | 25 mM in diet or 3 mg oral gavage | In vivo | St3gal4−/−, IL10−/−, St3gal4−/−;IL10−/− and TLR4−/− C57BL/J6 mice | Crossfostering Spontaneous chronic intestinal inflammation | Early onset and exacerbation of colitis symptoms, increased proinflammatory cytokines, proinflammatory monocytes, Th1 and Th17 cells | (Kurakevich et al., 2013) | |
Lauric acid | 50, 75, or 100 µM | In vitro | RAW264.7 and 293T cells transfected with TLR4 and MD2 | Dominant-negative mutant of TLR4, MyD88, IRAK-1, TRAF6, or IĸBα. I3K inhibitor (LY294002) or a dominant-negative mutant of PI3K or AKT | Activation of TLR4 and signaling pathways involving MyD88/IRAK/TRAF6 and PI3K/AKT | (Lee et al., 2003) | |
Short-chain GOS/long-chain FOS | 5 mg/ml | In vitro | Human monocyte–derived DCs | LPS, Bifidobacterium breve, and TLR4-specific antagonist | Induction of IL-10 secretion of (Bifidobacterium breve–stimulated) DCs | (Lehmann et al., 2015) | |
Palmitic acid | 50–300 µM | In vitro | Human monocyte–derived DCs and recombinant TLR4/MD2 HeLa cells | — | Upregulation of DC costimulatory factors CD86 and CD83 and expression of IL-1β by interacting with TLR4/MD-2 | (Nicholas et al., 2017) | |
Free fatty acids | 500 µM | In vitro/ex vivo | RAW264.7 cells and BMDC from WT and TLR2/4 double-KO C57BL/6 mice | RAW264.7 cells were treated with siRNA-TLR2/4 | Increase in proinflammatory cytokines | (Nguyen et al., 2007) | |
Goat milk oligosaccharides, inulin, GOS, and FOS | 5 mg/ml | In vitro/ex vivo | IEC18, HT29, Caco-2 and Caco‐2/TC7 cells and colon cells from WT and TLR4 KO C57BL/6J mice | Specific inhibitors of NF-κB and MAPK pathways, shRNA specific for MyD88 and TLR4 for gene knockdown | NDOs stimulated cytokine production in intestinal epithelial cells (e.g., CXCL-1 and MCP-1) | (Ortega-González et al., 2014) | |
High-fat diet Palmitate and oleate | Not specified (diet) 200 or 400 µM (in vitro) | In vivo/in vitro | WT and TLR4−/− C57BL6/J mice, ob/ob and db/db mice. RAW264.7 cells and 293T 3T3-L1 adipocytes, isolated mouse adipocytes, adipose tissue, and peritoneal macrophages from TLR4−/− mice | Diet-induced obesity siRNA-TLR4 | Diet-induced inflammation and insulin resistance, increased TLR4 expression in adipose tissue of obese/diabetic mice. Activation of TLR4 signaling, stimulation of cytokine expression (e.g., TNF-α, IL-6) | (Shi et al., 2006) | |
Palmitate | 100-200 µM | In vitro/ex vivo | Coculture of 3T3-L1 and RAW264.7, Ba/F3, or TLR4 mutant peritoneal macrophages of C3H/HeJ or C3H/HeN mice | TNF-α, LPS | Role of TLR4/NF-κB pathway in SFA-induced inflammatory changes | (Suganami et al., 2007) |
HEK, Human Embryonic Kidney; IEC, intestinal epithelial cell line; MAPK = Mitogen-Activated Protein Kinase; shRNA, short hairpin RNA.